Related Experiment Video
Updated: May 8, 2025

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
Published on: March 28, 2025
Strategies and Research Progress of Surface Antithrombotic Polymer Coating Under Inflammatory Conditions
Zehong Xiang1,2, Honghong Chen3, Feng Wu1,2
1Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 518000, China.
Abstract:
Cardiovascular diseases (CVD) is the leading causes of mortality globally. Various blood-contact medical devices, by applying anticoagulant coatings on the material surface. Utilizing various anticoagulants and enhancing the lubricity of medical device surfaces can effectively reduce short-term thrombotic risks. However, thrombosis in long-term or medium-to-long-term implanted devices remains a significant challenge. Current evidence suggests that during prolonged implantation, immune rejection of the device and its matrix, along with chronic inflammation induced by the disease, are key contributors to late-stage thrombosis. Therefore, modulating inflammation under pathological conditions is considered crucial for achieving long-term antithrombotic objectives. This review summarizes several representative antithrombotic coatings strategies based on anti-inflammatory and introduces some of the research contributions in this area.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

